Potential and progress in targeting less common markers: HER2, BRAF, KRAS, MET, TRK, and RET
Автор: HMP Education
Загружено: 2018-02-12
Просмотров: 156
Описание:
In this presentation from the 22nd Annual Perspectives in Thoracic Oncology, Dr. Joshua Bauml discusses the potential of and progress in targeteing less common markers including HER2, BRAF, KRAS, MET, TRK, and RET.
Earn CME credit for a related activity at the following location:
http://elc.imedex.com/ELC/Specialty-S...
© 2017 Imedex, LLC.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: